MK Capital has led a $15 million investment in HealthPlan Data Solutions to enhance its innovative pharmacy benefits management oversight technology.

Information on the Target

HealthPlan Data Solutions (HDS), located in Columbus, OH, specializes in pharmacy benefit oversight technology, offering innovative, data-driven solutions tailored specifically for the Pharmacy Benefits Management (PBM) industry. The company's flagship offering, the Spotlight Platform, comprises an array of tools including Claim Scan, Oversight & Analytics, Script Scan, and Reveal which assist health plans, self-insured employers, and specialty pharmacies in monitoring pharmacy claims, reducing waste, and ensuring compliance within PBM networks.

By harnessing real-time analytics and compliance tools, HDS empowers its clients to realize significant cost savings and improved transparency in their pharmacy benefit expenditures. This strategic approach promotes proactive monitoring as opposed to reactive audits, positioning HDS as a leader in transforming pharmacy benefit management oversight.

Industry Overview

The pharmacy benefits management sector is undergoing rapid transformation, largely driven by the necessity for enhanced transparency and regulatory compliance. In the United States, the market for PBM services continues to expand, fueled

View Source

Similar Deals

New Mountain Capital Smarter Technologies

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
Unifeye Vision Partners Brooks Eye Associates

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services United States of America
Advantage Capital Gravity Diagnostics

2025

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Eir Partners Porter

2025

Growth Equity & Expansion Capital Home Healthcare Services United States of America
Ampersand Capital Partners Lexington Medical

2025

Growth Equity & Expansion Capital Medical Devices & Implants United States of America
Ampersand Capital Partners Gannet BioChem

2025

Growth Equity & Expansion Capital Biopharmaceuticals United States of America

MK Capital

invested in

HealthPlan Data Solutions

in 2025

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $15M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert